Photocure ASA (LON:0IMT)
60.60
0.00 (0.00%)
At close: Sep 11, 2025
Photocure ASA Revenue
Photocure ASA had revenue of 135.62M NOK in the quarter ending June 30, 2025, a decrease of -6.76%. This brings the company's revenue in the last twelve months to 522.86M, up 1.81% year-over-year. In the year 2024, Photocure ASA had annual revenue of 525.39M with 4.94% growth.
Revenue (ttm)
522.86M NOK
Revenue Growth
+1.81%
P/S Ratio
3.13
Revenue / Employee
5.18M NOK
Employees
101
Market Cap
118.02M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 525.39M | 24.73M | 4.94% |
Dec 31, 2023 | 500.66M | 107.53M | 27.35% |
Dec 31, 2022 | 393.13M | 32.59M | 9.04% |
Dec 31, 2021 | 360.54M | 104.06M | 40.57% |
Dec 31, 2020 | 256.48M | -25.07M | -8.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Photocure ASA News
- 6 weeks ago - Photocure ASA: Results for the second quarter of 2025 - PRNewsWire
- 4 months ago - Photocure ASA: Results for the first quarter of 2025 - PRNewsWire
- 7 months ago - Photocure ASA: Results for the fourth quarter of 2024 - PRNewsWire
- 10 months ago - Photocure ASA: Results for the third quarter of 2024 - PRNewsWire
- 1 year ago - Photocure ASA: Results for the second quarter of 2024 - PRNewsWire